Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

The cost-effectiveness of rotavirus vaccination in Armenia.

Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L.

Vaccine. 2011 Nov 8;29(48):9104-11. doi: 10.1016/j.vaccine.2011.08.127.

PMID:
21945959
2.

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

Standaert B, Parez N, Tehard B, Colin X, Detournay B.

Appl Health Econ Health Policy. 2008;6(4):199-216. doi: 10.2165/00148365-200806040-00003.

PMID:
19382820
3.

Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.

De la Hoz F, Alvis N, Narváez J, Cediel N, Gamboa O, Velandia M.

Vaccine. 2010 May 14;28(22):3856-64. doi: 10.1016/j.vaccine.2010.03.004.

PMID:
20347057
4.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052.

PMID:
22119590
5.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

6.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6.

PMID:
16235169
7.

[Potential cost effectiveness of a rotavirus vaccine in Chile].

Constenla D, O'Ryan M, Navarrete MS, Antil L, Rheingans RD.

Rev Med Chil. 2006 Jun;134(6):679-88. Spanish.

8.
9.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
10.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
11.

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.

Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, Barry M.

Vaccine. 2011 Oct 6;29(43):7463-73. doi: 10.1016/j.vaccine.2011.07.056.

PMID:
21821085
12.

Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.

Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.

J Med Econ. 2011;14(6):748-58. doi: 10.3111/13696998.2011.614303.

PMID:
21919673
13.

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.

Abbott C, Tiede B, Armah G, Mahmoud A.

Vaccine. 2012 Mar 28;30(15):2582-7. doi: 10.1016/j.vaccine.2012.01.076.

PMID:
22321664
14.

Cost-effectiveness of Rotavirus vaccination in Vietnam.

Kim SY, Goldie SJ, Salomon JA.

BMC Public Health. 2009 Jan 21;9:29. doi: 10.1186/1471-2458-9-29.

15.

Cost-effectiveness of childhood rotavirus vaccination in Taiwan.

Wu CL, Yang YC, Huang LM, Chen KT.

Vaccine. 2009 Mar 4;27(10):1492-9. doi: 10.1016/j.vaccine.2009.01.023.

PMID:
19186200
16.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

PMID:
19817595
17.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
18.

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C.

Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074.

PMID:
25919152
19.

Economic impact of a rotavirus vaccination program in Mexico.

Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y.

Rev Panam Salud Publica. 2009 Jun;25(6):481-90.

20.

Economic evaluation of a routine rotavirus vaccination programme in Indonesia.

Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A.

Vaccine. 2009 Nov 20;27 Suppl 5:F67-74. doi: 10.1016/j.vaccine.2009.09.040.

PMID:
19931723

Supplemental Content

Support Center